Walsall Manor Hospital Trials

Walsall Manor Hospital	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Person, Contact

PATCH, NCT00303784 / 2005-001030-33: Prostate Adenocarcinoma TransCutaneous Hormones

Recruiting

2200

Europe

Goserelin, Zoladex, Estradiol, FemSeven

University College, London, Medical Research Council

Anemia, Cardiovascular Complications, Hot Flashes, Osteoporosis, Prostate Cancer

08/21

UKALL14, NCT01085617 / 2009-012717-22: Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Active, not recruiting

1033

palifermin, rituximab, cyclophosphamide, cytarabine, daunorubicin hydrochloride, etoposide, fludarabine phosphate, imatinib mesylate, melphalan, mercaptopurine, methotrexate, nelarabine, pegaspargase, vincristine sulfate, allogeneic hematopoietic stem cell transplantation, total-body irradiation

University College, London

Leukemia, Mucositis, Oral Complications

12/24

12/25

STAMPEDE, NCT00268476: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

Active, not recruiting

2/3

11992

Europe

Celecoxib, Celebrex, Docetaxel, Taxotere, Prednisolone, Prednisone, ADT, Androgen Deprivation Therapy, Zoledronic Acid, Zometa, Abiraterone, Zytiga, Radiotherapy to the prostate, RT, Enzalutamide, Xtandi, Metformin, Metformin Hydrochloride, Transdermal Oestradiol, Progynova TS

Medical Research Council

Prostate Cancer

03/26

12/30

NCT00589017: Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy

Recruiting

US, Europe

tamoxifen citrate, immunohistochemistry staining method, laboratory biomarker analysis

Baylor College of Medicine

Bladder Cancer

07/10

NCT03412643: Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

Recruiting

Doxorubicin, Cyclophosphamide, Weekly Paclitaxel, Trastuzumab, Pertuzumab, Celcuity CELx HSF

NSABP Foundation Inc, Celcuity, LLC, Genentech, Inc.

HER2-negative Breast Cancer

10/23

PRISM, NCT03658525: Prostate Radiotherapy Integrated With Simultaneous MRI (The Study)

Recruiting

N/A

Europe

MR LINAC

Royal Marsden NHS Foundation Trust

Prostate Cancer

08/20

08/23

NCT06032663: Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications

Recruiting

N/A

Europe

PET-MRI

Sheffield Teaching Hospitals NHS Foundation Trust

Head and Neck Cancer

10/24

10/25

NCT01840293: Breast Cancer Proteomics and Molecular Heterogeneity

Recruiting

N/A

1780

Europe

Cancer Trials Ireland

Primary Breast Cancer, Recurrent/Metastatic Breast Cancer

12/29

01/38

Iqbal, Mohammed

NCT05699057: Tendency to Suicide as a Sequel of Computer Vision Syndrome

Completed

N/A

3512

RoW

Suicide GROUP

Sohag University

Computer Vision Syndrome

02/23

03/23

NCT01191151: Web Based Orthopaedic Sports Medicine Registry

Terminated

N/A

12500

Europe, Canada, US, RoW

Arthrex, Inc.

Degenerative and Traumatic Pathology of the Knee, Degenerative and Traumatic Pathology of the Shoulder and Elbow, Degenerative and Traumatic Pathology of the Foot and Ankle, Degenerative and Traumatic Pathology of the Hand and Wrist, Degenerative and Traumatic Pathology of the Hip

07/23

Kundra, Rik

NCT01191151: Web Based Orthopaedic Sports Medicine Registry

Terminated

N/A

12500

Europe, Canada, US, RoW

Arthrex, Inc.

07/23

Jaumdally, Rumi

EASY-AS, NCT04204915: The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study

Recruiting

N/A

2844

Europe, RoW

Aortic valve replacement

University of Leicester, University of Auckland, New Zealand, University Hospitals, Leicester, The University of Western Australia

Aortic Stenosis

04/31



	Diseases Companies Products Productz Mechanisms of Action Sites